Debt (Details) - USD ($) |
4 Months Ended | 12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|
Nov. 23, 2022 |
Nov. 07, 2022 |
Dec. 31, 2023 |
Dec. 31, 2023 |
Dec. 31, 2021 |
Dec. 31, 2022 |
Sep. 30, 2021 |
Jun. 30, 2021 |
May 04, 2020 |
|
| Debt [Line Items] | |||||||||
| Description of interest rate | Kinergy has an operating line of credit for an aggregate amount of up to $100,000,000. The line of credit matures on November 7, 2027. The credit facility is based on Kinergy’s eligible accounts receivable and inventory levels, subject to certain concentration reserves. The credit facility is subject to certain other sublimits, including inventory loan limits. Interest accrues under the line of credit at a rate equal to (i) the daily Secured Overnight Financing Rate, plus (ii) a specified applicable margin ranging between 1.25% and 1.75%. The applicable margin was 1.25%, for a total rate of 6.74%, at December 31, 2023. The credit facility’s monthly unused line fee is an annual rate equal to 0.25% to 0.375% depending on the average daily principal balance during the immediately preceding month. Payments that may be made by Kinergy to the Company as reimbursement for management and other services provided by the Company to Kinergy are limited under the terms of the credit facility to $1,500,000 per fiscal quarter. The credit facility also includes the accounts receivable of Alto Nutrients as additional collateral. Payments that may be made by Alto Nutrients to the Company as reimbursement for management and other services provided by the Company to Alto Nutrients are limited under the terms of the credit facility to $500,000 per fiscal quarter. Kinergy and Alto Nutrients may also make distributions to the Company of up to 75% of their excess cash flow. | ||||||||
| Operating line of credit | $ 100,000,000 | $ 100,000,000 | |||||||
| Line of credit matures | Nov. 07, 2027 | ||||||||
| Excess percentage | 75.00% | ||||||||
| Unused borrowing | $ 33,300,000 | $ 33,300,000 | |||||||
| Senior secured credit amount | $ 125,000,000 | ||||||||
| Lenders company advances | 100,000,000 | ||||||||
| Additional fees | $ 25,000,000 | ||||||||
| Lenders stock share issued (in Shares) | 1,282,051 | 1,282,051 | |||||||
| Additional lenders stock share issued (in Shares) | 320,513 | 320,513 | |||||||
| Initial funding | $ 60,000,000 | ||||||||
| Issuance of shares (in Shares) | 1,282,051 | ||||||||
| Outstanding amount | $ 60,000,000 | $ 60,000,000 | $ 60,000,000 | ||||||
| Loan proceeds | $ 3,912,000 | ||||||||
| Percentage of fixed rate | 10.00% | 10.00% | |||||||
| Specified leverage | The Company must prepay amounts outstanding under the Term Loan on a semi-annual basis beginning with the six-month period ended December 31, 2023 in an amount equal to a percentage of the Company’s excess cash flow based on a specified leverage ratio, as follows: (i) if the leverage ratio is greater than or equal to 3.0x, then the mandatory prepayment amount will equal 100% of the Company’s excess cash flow, (ii) if the leverage ratio is less than 3.0x and greater than or equal to 1.5x, then the mandatory prepayment amount will equal 50% of the Company’s excess cash flow and (iii) if the leverage ratio is less than 1.5x, then the mandatory prepayment amount will equal 25% of the Company’s excess cash flow. | ||||||||
| Principal amount | $ 6,000,000 | $ 3,900,000 | |||||||
| Income from loan forgiveness | $ 9,900,000 | ||||||||
| Minimum [Member] | |||||||||
| Debt [Line Items] | |||||||||
| Applicable ranging percentage | 1.25% | ||||||||
| Applicable margin percentage | 1.25% | ||||||||
| Unused line fee percentage | 0.25% | ||||||||
| Maximum [Member] | |||||||||
| Debt [Line Items] | |||||||||
| Applicable ranging percentage | 1.75% | ||||||||
| Applicable margin percentage | 6.74% | ||||||||
| Unused line fee percentage | 0.375% | ||||||||
| Alto Ingredients [Member] | |||||||||
| Debt [Line Items] | |||||||||
| Loan proceeds | $ 6,000,000 | ||||||||
| Alto Pekin [Member] | |||||||||
| Debt [Line Items] | |||||||||
| Loan proceeds | $ 3,900,000 | ||||||||
| Kinergy [Member] | |||||||||
| Debt [Line Items] | |||||||||
| Credit facility | $ 1,500,000 | ||||||||
| Alto Nutrients [Member] | |||||||||
| Debt [Line Items] | |||||||||
| Credit facility | $ 500,000 | ||||||||
| X | ||||||||||
- Definition Additional lenders agreed to advance loans amount. No definition available.
|
| X | ||||||||||
- Definition Additional lenders stock share issued. No definition available.
|
| X | ||||||||||
- Definition Lenders agreed to advance loans amount. No definition available.
|
| X | ||||||||||
- Definition Lenders stock share issued. No definition available.
|
| X | ||||||||||
- Definition Line of credit facility applicable margin percentage. No definition available.
|
| X | ||||||||||
- Definition Line of credit facility, applicable ranging. No definition available.
|
| X | ||||||||||
- Definition The amount of senior secured credit facility. No definition available.
|
| X | ||||||||||
- Definition Description of specified leverage. No definition available.
|
| X | ||||||||||
- Definition Number of common units issued of limited liability company (LLC). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of interest and fee income from loans classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used. No definition available.
|
| X | ||||||||||
- Definition Date the credit facility terminates, in YYYY-MM-DD format. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The effective interest rate at the end of the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Description of interest rate for borrowing under credit facility. Includes, but is not limited to, terms and method for determining interest rate. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Maximum month-end amount borrowed under the credit facility during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility. No definition available.
|
| X | ||||||||||
- Definition This element represents the current and noncurrent portions of a long-term real estate loan with an initial maturity beyond one year or beyond the normal operating cycle, if longer, to finance building costs. The funds are disbursed as needed or in accordance with a prearranged plan; generally, a portion of the funds is disbursed at inception and the remainder as construction progresses. The money is repaid on completion of the project (generally one to seven years), usually from the proceeds of a mortgage loan. The rate is normally higher than the prime rate, and there is usually an origination fee. The effective yield on these loans tends to be high, and the lender has a security interest in the real property. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Including the current and noncurrent portions, carrying value as of the balance sheet date of all notes and loans payable (with maturities initially due after one year or beyond the operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The initial funding or additional funding of loans receivable to policy holders principally secured by the benefits under the policy. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Cash received from principal payments made on loans related to operating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|